Cardiac Dysfunction and Metabolic Inflexibility in a Mouse Model of Diabetes Without Dyslipidemia

Diabetes is a well-established risk factor for heart disease, leading to impaired cardiac function and a metabolic switch toward fatty acid usage. In this study, we investigated if hyperglycemia/hypoinsulinemia in the absence of dyslipidemia is sufficient to drive these changes and if they can be reversed by restoring euglycemia. Using the βV59M mouse model, in which diabetes can be rapidly induced and reversed, we show that stroke volume and cardiac output were reduced within 2 weeks of diabetes induction. Flux through pyruvate dehydrogenase was decreased, as measured in vivo by hyperpolarized [1-13C]pyruvate MRS. Metabolomics showed accumulation of pyruvate, lactate, alanine, tricarboxyclic acid cycle metabolites, and branched-chain amino acids. Myristic and palmitoleic acid were decreased. Proteomics revealed proteins involved in fatty acid metabolism were increased, whereas those involved in glucose metabolism decreased. Western blotting showed enhanced pyruvate dehydrogenase kinase 4 (PDK4) and uncoupling protein 3 (UCP3) expression. Elevated PDK4 and UCP3 and reduced pyruvate usage were present 24 h after diabetes induction. The observed effects were independent of dyslipidemia, as mice showed no evidence of elevated serum triglycerides or lipid accumulation in peripheral organs (including the heart). The effects of diabetes were reversible, as glibenclamide therapy restored euglycemia, cardiac metabolism and function, and PDK4/UCP3 levels.

[1]  M. Hecker,et al.  Role of protein carbonylation in diabetes , 2018, Journal of Inherited Metabolic Disease.

[2]  S. Persaud,et al.  Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential , 2017, Pharmacology & therapeutics.

[3]  R. Tian,et al.  Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury. , 2017, Cell metabolism.

[4]  F. Charpentier,et al.  The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model , 2017, Diabetes.

[5]  J. Sowers,et al.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease , 2017, Diabetologia.

[6]  F. Ashcroft,et al.  Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells , 2016, Nature Communications.

[7]  K. Gopal,et al.  Lipotoxicity in obesity and diabetes-related cardiac dysfunction. , 2016, Biochimica et biophysica acta.

[8]  F. Powrie,et al.  Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes , 2016, Scientific Reports.

[9]  Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes , 2016, Current Cardiology Reports.

[10]  R. Tian,et al.  Glucose Transporters in Cardiac Metabolism and Hypertrophy. , 2015, Comprehensive Physiology.

[11]  J. Schilling The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise. , 2015, Antioxidants & redox signaling.

[12]  K. Clarke,et al.  Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study , 2015, Diabetes.

[13]  F. Ashcroft,et al.  Reversible changes in pancreatic islet structure and function produced by elevated blood glucose , 2014, Nature Communications.

[14]  R. Neviere,et al.  Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients , 2014, Circulation.

[15]  M. Kinter,et al.  Rapid Inhibition of Pyruvate Dehydrogenase: An Initiating Event in High Dietary Fat-Induced Loss of Metabolic Flexibility in the Heart , 2013, PloS one.

[16]  Choon Nam Ong,et al.  Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. , 2013, The Journal of clinical endocrinology and metabolism.

[17]  K. Drosatos,et al.  Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications , 2013, Current Heart Failure Reports.

[18]  K. Clarke,et al.  In vivo mouse cardiac hyperpolarized magnetic resonance spectroscopy , 2013, Journal of Cardiovascular Magnetic Resonance.

[19]  L. Wold,et al.  Metabolic dysfunction in diabetic cardiomyopathy , 2013, Heart Failure Reviews.

[20]  E. Abel,et al.  Insulin resistance: metabolic mechanisms and consequences in the heart. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[21]  K. Yea,et al.  The transcriptional coactivators, PGC-1α and β, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance. , 2012, Journal of molecular and cellular cardiology.

[22]  Jacob G. Bundy,et al.  A software complement to AMDIS for processing GC-MS metabolomic data. , 2011, Analytical biochemistry.

[23]  G. Gibson,et al.  Inactivation and Reactivation of the Mitochondrial α-Ketoglutarate Dehydrogenase Complex* , 2011, The Journal of Biological Chemistry.

[24]  K. Clarke,et al.  A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart , 2011, Basic Research in Cardiology.

[25]  A. Haase,et al.  FLASH imaging: rapid NMR imaging using low flip-angle pulses. 1986. , 1986, Journal of magnetic resonance.

[26]  D. Hardie,et al.  PGC-1alpha increases PDH content but does not change acute PDH regulation in mouse skeletal muscle. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[27]  P. Neufer,et al.  Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. , 2009, Journal of the American College of Cardiology.

[28]  J. Bryan,et al.  Neonatal diabetes mellitus. , 2008, Endocrine reviews.

[29]  Xianlin Han,et al.  CD36 Deficiency Rescues Lipotoxic Cardiomyopathy , 2007, Circulation research.

[30]  D. Kelly,et al.  Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-&agr;/PGC-1&agr; Gene Regulatory Pathway , 2007, Circulation.

[31]  Kieran Clarke,et al.  Fast, high‐resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system , 2003, Journal of magnetic resonance imaging : JMRI.

[32]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Kieran Clarke,et al.  Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes , 2003, Circulation.

[34]  C. Kahn,et al.  Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. , 2002, The Journal of clinical investigation.

[35]  Robert A. Harris,et al.  Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. , 2002, Diabetes.

[36]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[37]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[38]  Jennifer Y. Liu,et al.  Glycemic Control and Heart Failure Among Adult Patients With Diabetes , 2001, Circulation.

[39]  K. M. Popov,et al.  Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. , 1998, The Biochemical journal.

[40]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[41]  J. Chatham,et al.  The effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase activity. , 1997, Journal of molecular and cellular cardiology.

[42]  J. Chatham,et al.  Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. , 1997, The American journal of physiology.

[43]  J. Mccormack,et al.  Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. , 1996, The American journal of physiology.

[44]  R. Miller,et al.  Branched-chain amino acid metabolism. , 1984, Annual review of nutrition.

[45]  D L McGee,et al.  Diabetes and Cardiovascular Risk Factors: The Framingham Study , 1979, Circulation.

[46]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.